Search
for
Sort by
Research 61–90 of 1000+
- Dermatological manifestations of COVID-19 and its therapies: a review
- Cutaneous Adverse Effects of EGFR Therapy in Breast Cancer Treatment
- Rare Cutaneous Side Effects of Imiquimod: A Review on Its Mechanisms, Diagnosis, and Management
- Cutaneous complications of chemotherapeutic agents
- Psychoactive drugs and skin
- Dermatologic Conditions of the Early Post-Transplant Period in Hematopoietic Stem Cell Transplant Recipients
- Adverse Dermatologic Effects of Cardiovascular Drug Therapy: Part III
- Cutaneous effects of the most commonly used antidepressant medication, the selective serotonin reuptake inhibitors
- Exacerbation of subacute cutaneous lupus erythematosus following vaccination with BNT162b2 mRNA vaccine
- Management of Cutaneous and Extracutaneous Side Effects of Smoothened Inhibitor Therapy for Advanced Basal Cell Carcinoma
- Alopecia secondary to anti-tumor necrosis factor-alpha therapy
- MULTISYSTEM ADVERSE EFFECTS OF ISOTRETINOIN: MECHANISTIC INSIGHTS AND CLINICAL IMPLICATIONS
- Harmless Herbs? A Review of the Recent Literature
- Confirmation of Metformin-Induced Acute Generalized Exanthematous Pustulosis Through a Positive Dechallenge-Rechallenge Test: A Case Report and Review of Cutaneous Manifestations Associated With Metformin
- Psychotropic Medications and the Skin
- Dermatologic Adverse Events from Cancer Treatments
- Leflunomide-Induced Cutaneous Ulcers: A Rare Diagnostic Conundrum
- Sorafenib stimulates human skin type mast cell degranulation and maturation
- Cyclin-Dependent Kinase 4/6 Inhibitors and Dermatologic Adverse Events: Results from the EADV Task Force “Dermatology for Cancer Patients” International Study
- Tolerability of hair cleansing conditioners: a double-blind randomized, controlled trial designed to evaluate consumer complaints to the U.S. Food and Drug Administration
- Hypersensitivity Reactions to Anticoagulant Drugs
- Tumour regression predicts higher risk of sentinel node involvement in thin cutaneous melanomas
- Lupus erythematosus: considerations about clinical, cutaneous and therapeutic aspects
- JAK kinase pathway inhibitor drugs in patients with moderate-to-severe alopecia: a real-world experience
- Severe Infliximab-Induced Alopecia and Scalp Psoriasis in a Woman with Crohn’s Disease: Dramatic Improvement after Drug Discontinuation and Treatment with Adjuvant Systemic and Topical Therapies
- Anthelminthic drugs
- Antihelminthic Drugs
- Acute vesiculobullous hand dermatitis and anagen effluvium in Ganoderma lucidum-induced aplastic crisis
- Topical imiquimod—Be aware of the unexpected
- Real-world safety of ixekizumab: a disproportionality analysis using the FDA adverse event reporting system and the VigiAccess databases